Clinical trial · Interventional
Anesthesia and Cancer Study: Renal Cell Carcinoma
The Influence of Type of Anesthesia on Recurrence of Renal Cell Carcinoma After Nephrectomy: a Prospective Randomized Controlled Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigates the influence of type of anesthesia on recurrence and survival of renal cell carcinoma in patients undergoing nephrectomy. The participants will be allocated to either the group receiving the total intravenous anesthesia (TIVA) using propofol or the group receiving the inhaled anesthetics, such as sevoflurane or desflurane.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Inhaled General Anesthetics | Drug | — | UNRESOLVED |
| Propofol | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- TIVA group
- description
- Patients receiving the total intravenous anesthesia using propofol
- interventionNames
- Drug: Propofol
- type
- ACTIVE_COMPARATOR
- label
- inhalation group
- description
- Patients receiving inhalation anesthesia using sevoflurane or desflurane
- interventionNames
- Drug: Inhaled General Anesthetics
Primary outcomes (1)
- measure
- five year metastasis-free survival
- timeFrame
- five year after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients scheduled for elective nephrectomy due to renal cell carcinoma Exclusion Criteria: * Emergency surgery * Pregnancy * Allergies to anesthetics * Palliative surgery * Refusal to participate in the study * History of diagnosis or surgery for other cancer
References
Publications (0)
Data not yet available